GlassScriptPhysician profile
Alissa J Redding
NPI 1760614390
$16,147.31
in general payments reported to CMS, 2019-2025
7 companies · $34.54 in 2025
The $34.54 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,506 · 2020: $2,428 · 2021: $3,846 · 2022: $1,250 · 2023: $1,290 · 2024: $1,793 · 2025: $34.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,479 · Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,479.33 |
| Food and Beverage | $638.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $9,999.99 | 2019-2024 | |
| Gemini Medical LLC | $3,628.05 | 2019-2021 | |
| Foundation Medical, LLC | $2,417.03 | 2022-2024 | |
| Organogenesis INC. | $34.42 | 2019-2021 | |
| Stryker Corporation | $33.28 | 2022 | |
| Biocomposites INC | $18.51 | 2025 | Stimulan |
| Kerecis Limited | $16.03 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alissa Redding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.